stars 1 stars 2 stars 3

iMAb supplies human monoclonal antibody leads to biotechnology and pharmaceutical companies, with a view to their development and marketing for therapeutic or diagnostic applications. To that end, iMAb's mission is to generate antibody hits developed to match customer specifications and, at lead validation, to transfer the lead antibody sequence along with full ownership and exclusive rights for the customer to carry on its drug development.

iMAb Questions

The iMAb annual revenue was $1 million in 2026.

Sylvain Yon is the CEO of iMAb.

18 people are employed at iMAb.

The NAICS codes for iMAb are [52, 525, 81, 5259, 813, 52591].

The SIC codes for iMAb are [673, 67, 672].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users